← Back
$TVTX All transactions

Travere Therapeutics, Inc.

M 10b5-1 Plan

$ Value

$131K

Shares

8,000

Price

$16

Filed

Nov 4

Insider

Name

Coughlin Timothy

Title

CIK

0001376043

Roles

Director

Transaction Details

Transaction Date

2025-10-31

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

63,500

Footnotes

This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended. | The weighted average sale price for the transaction reported was $35.0334, and the range of prices were between $35.00 and $35.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided. | The stock option is fully vested and exercisable.

Filing Info

Accession No.

0001376043-25-000004

Form Type

4

Issuer CIK

0001438533

Coughlin Timothy's History

Date Ticker Type Value
2025-10-31 TVTX M $131K
2025-10-31 TVTX M $174K
2025-10-31 TVTX $631K
2025-10-31 TVTX M $0
2025-10-31 TVTX M $0
2025-06-03 ADCT A $0
2025-06-03 ADCT A $0
2025-05-15 TVTX A $0
2025-05-15 TVTX A $0
2025-05-01 ATYR A $0

Other Insiders at TVTX (90d)

Insider Bought Sold Last
LYONS GARY A $329K 2026-04-14
REED ELIZABETH E
Chief Legal Officer and GC
$2.1M 2026-04-15
REED ELIZABETH E / Heerma Peter / Inrig Jula
Chief Legal Officer and GC
$303K 2026-04-14
Baynes Roy D. $1.7M 2026-04-14
ROTE WILLIAM E.
Chief Research Officer
$356K 2026-04-22
Dube Eric M
CHIEF EXECUTIVE OFFICER
$4.5M 2026-04-15
Heerma Peter
CHIEF COMMERCIAL OFFICER
2026-04-13
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER
$903K 2026-04-14
Inrig Jula
CHIEF MEDICAL OFFICER
$43K 2026-04-15
Cline Christopher R.
CHIEF FINANCIAL OFFICER
$349K 2026-04-15